Literature DB >> 32365034

Netboost: Boosting-Supported Network Analysis Improves High-Dimensional Omics Prediction in Acute Myeloid Leukemia and Huntington's Disease.

Pascal Schlosser, Jochen Knaus, Maximilian Schmutz, Konstanze Dohner, Christoph Plass, Lars Bullinger, Rainer Claus, Harald Binder, Michael Lubbert, Martin Schumacher.   

Abstract

State-of-the art selection methods fail to identify weak but cumulative effects of features found in many high-dimensional omics datasets. Nevertheless, these features play an important role in certain diseases. We present Netboost, a three-step dimension reduction technique. First, a boosting-based filter is combined with the topological overlap measure to identify the essential edges of the network. Second, sparse hierarchical clustering is applied on the selected edges to identify modules and finally module information is aggregated by the first principal components. We demonstrate the application of the newly developed Netboost in combination with CoxBoost for survival prediction of DNA methylation and gene expression data from 180 acute myeloid leukemia (AML) patients and show, based on cross-validated prediction error curve estimates, its prediction superiority over variable selection on the full dataset as well as over an alternative clustering approach. The identified signature related to chromatin modifying enzymes was replicated in an independent dataset, the phase II AMLSG 12-09 study. In a second application we combine Netboost with Random Forest classification and improve the disease classification error in RNA-sequencing data of Huntington's disease mice. Netboost is a freely available Bioconductor R package for dimension reduction and hypothesis generation in high-dimensional omics applications.

Entities:  

Mesh:

Year:  2021        PMID: 32365034     DOI: 10.1109/TCBB.2020.2983010

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.710


  2 in total

1.  Decreased complement 4d increases poor prognosis in patients with non-small cell lung cancer combined with gastrointestinal lymph node metastasis.

Authors:  Yan Wang; Mengqi Xiang; Huachuan Zhang; Yongda Lu
Journal:  Exp Ther Med       Date:  2022-07-05       Impact factor: 2.751

2.  Serum Metabolites and Kidney Outcomes: The Atherosclerosis Risk in Communities Study.

Authors:  Lauren Bernard; Linda Zhou; Aditya Surapaneni; Jingsha Chen; Casey M Rebholz; Josef Coresh; Bing Yu; Eric Boerwinkle; Pascal Schlosser; Morgan E Grams
Journal:  Kidney Med       Date:  2022-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.